Leonard S. Schleifer, President & CEO at REGENERON PHARMACEUTICALS INC (REGN), sold 1,500 shares at $413.88 ($616K) on 2015-01-02, disclosed to the SEC on 2015-01-05.
Scheduled sale ($616k) by President & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $408.64 | 397 | $162K | 26.3% |
| 2 | $409.28 | 300 | $123K | 19.9% |
| 3 | $410.47 | 403 | $165K | 26.9% |
| 4 | $412.23 | 200 | $82K | 13.4% |
| 5 | $413.88 | 100 | $41K | 6.7% |
| 6 | $416.00 | 100 |
| $42K |
| 6.8% |
| Total | $410.58 avg | 1,500 | $616K | 100% |
| Filing → |
| REGN | SELL | 2024-05-17 | $44.7M | — | Filing → |
| REGN | SELL | 2024-05-15 | $70.1M | — | Filing → |
| REGN | SELL | 2022-04-07 | $10.1M | — | Filing → |